Primary Job Title Head of Corporate Development & Co-Founder Primary Organization 
Mereo Biopharma
Location Greater Atlanta Area, Georgia, United States Regions East Coast, Southern US Gender Male
Investor Type
LinkedIn View on LinkedIn
John is based in Atlanta, Georgia USA and has worked with the team for twelve years. John assists with strategic and commercial diligence activities and has represented Phase4 Partners on the board of Targacept, Altus and Immgenics (acquired by Abgenix) and currently represents Phase4 Partners on the board of Zosano. John is also Senior Business
Advisor at Phase4 Partners’ portfolio companies, Albireo and Nabriva.
As well as John’s role at Phase4 Partners, he is also a partner with Georgia Venture Partners, a seed stage venture company investing in Georgia biosciences. He was previously at SEQUUS where he was responsible for negotiating the acquisition of the company by ALZA (a subsidiary of Johnson & Johnson) and he was the CEO and co-founder of Impath Inc., which became part of Genzyme.
John received his MBA from Harvard and his BS from Stanford.
